License-Out
License Agreement Has Been Entered with Asahi Kasei Corp.
We executed a worldwide license agreement with Asahi Kasei Corp. (Tokyo, Japan) for the use of iPS cell-derived cartilage for regenerative t...
License-Out
We executed a worldwide license agreement with Asahi Kasei Corp. (Tokyo, Japan) for the use of iPS cell-derived cartilage for regenerative t...
results 111 - 120 of 222
Other
New patent information relates to iPS cell technologies for the month of September 2018 has been updated. Please see Related Patent Info. fo...
Event
We very much appreciate your visits to our booth at "BioJapan2018" in Yokohama from October 10th (Wed.) till October 12th (Fri.), 2018. The ...
License-Out
We executed a non-exclusive license agreement with SCAD for providing their products related to iPS cell-derived cardiomyocytes for research...
Other
New patent information relates to iPS cell technologies for the month of August 2018 has been updated. Please see Related Patent Info. for m...
License-Out
We executed a non-exclusive license agreement with Novoheart Limited (Hong Kong) for providing their products and services related to iPS ce...
License-In
We released the summary of 1 newly published patent application from our "Patent Portfolio" as follows. AJ159 Method for producing CD8α+β+ c...
Other
New patent information relates to iPS cell technologies for the month of July 2018 has been updated. Please see Related Patent Info. for mor...
Other
Our office will be closed for the summer holiday from Monday 13th August 2018 to Wednesday 15th August 2018. Please understand that our earl...
Other
New patent information relates to iPS cell technologies for the month of June 2018 has been updated. Please see Related Patent Info. for mor...